Rhythm Biosciences proves its colorectal cancer test is for real; shares up nearly 600pc in 8 months

Rhythm Biosciences (ASX:RHY) shares climbed again today after achieving its latest milestone – completing a prototype test kit. The company is … Read More

The post Rhythm Biosciences proves its colorectal cancer test is for real; shares up nearly 600pc in 8 months appeared first on Stockhead.

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *